Overview
- 180 inspections across 152 sites are on record.
- 213 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-17.
At a glance
Inspections
180
Sites
152
Observations
213
Career since
Feb 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| ClorDiSys Solutions, Inc. | 17 Jun 2026 | Human Drugs | View 483 → |
| New Jersey Laboratories | 12 May 2026 | Human Drugs | View 483 → |
| QualTech Laboratories, Inc. | 13 Apr 2026 | Human Drugs | View 483 → |
| Eurofins Infinity Laboratory Group,Inc. | 5 Mar 2026 | Human Drugs | |
| W. R. Grace & Company | 2 Mar 2026 | Human Drugs |
Sites inspected
ClorDiSys Solutions, Inc.Branchburg, United States1 insp.
New Jersey LaboratoriesNew Brunswick, United States1 insp.
QualTech Laboratories, Inc.Ocean, United States1 insp.
Eurofins Infinity Laboratory Group,Inc.Crown Point, United States1 insp.
W. R. Grace & CompanySouth Haven, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Nicholas A Violand6 shared
Addam S Reynolds5 shared
Barbara J Wilimczyk-Macri3 shared
Dorothy J Denes3 shared
Daniel J Min2 shared
Stephen J Mottola2 shared
Adetutu M Gidado2 shared
James R Birkenstamm2 shared
Saleem A Akhtar2 shared
Atul Agrawal2 shared
Full investigator report
Get the verbatim findings behind Frederick Razzaghi's 213 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site